BACKGROUND AND OBJECTIVES: Recent interest has focused on wait listing patients without pretreating coronary artery disease to expedite transplantation. Our practice is to offer coronary revascularization before transplantation if indicated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Between 2006 and 2009, 657 patients (427 men, 230 women; ages, 56.5 ± 9.94 years) underwent pretransplant assessment with coronary angiography. 573 of 657 (87.2%) patients were wait listed; 247 of 573 (43.1%) patients were transplanted during the follow-up period, 30.09 ± 11.67 months. RESULTS: Patient survival for those not wait listed was poor, 83.2% and 45.7% at 1 and 3 years, respectively. In wait-listed patients, survival was 98.9% and 95.3% at 1 and 3 years, respectively. 184 of 657 (28.0%) patients were offered revascularization. Survival in patients (n = 16) declining revascularization was poor: 75% survived 1 year and 37.1% survived 3 years. Patients undergoing revascularization followed by transplantation (n = 51) had a 98.0% and 88.4% cardiac event-free survival at 1 and 3 years, respectively. Cardiac event-free survival for patients revascularized and awaiting deceased donor transplantation was similar: 94.0% and 90.0% at 1 and 3 years, respectively. CONCLUSIONS: Our data suggest pre-emptive coronary revascularization is not only associated with excellent survival rates in patients subsequently transplanted, but also in those patients waiting on dialysis for a deceased donor transplant.
BACKGROUND AND OBJECTIVES: Recent interest has focused on wait listing patients without pretreating coronary artery disease to expedite transplantation. Our practice is to offer coronary revascularization before transplantation if indicated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Between 2006 and 2009, 657 patients (427 men, 230 women; ages, 56.5 ± 9.94 years) underwent pretransplant assessment with coronary angiography. 573 of 657 (87.2%) patients were wait listed; 247 of 573 (43.1%) patients were transplanted during the follow-up period, 30.09 ± 11.67 months. RESULTS:Patient survival for those not wait listed was poor, 83.2% and 45.7% at 1 and 3 years, respectively. In wait-listed patients, survival was 98.9% and 95.3% at 1 and 3 years, respectively. 184 of 657 (28.0%) patients were offered revascularization. Survival in patients (n = 16) declining revascularization was poor: 75% survived 1 year and 37.1% survived 3 years. Patients undergoing revascularization followed by transplantation (n = 51) had a 98.0% and 88.4% cardiac event-free survival at 1 and 3 years, respectively. Cardiac event-free survival for patients revascularized and awaiting deceased donor transplantation was similar: 94.0% and 90.0% at 1 and 3 years, respectively. CONCLUSIONS: Our data suggest pre-emptive coronary revascularization is not only associated with excellent survival rates in patients subsequently transplanted, but also in those patients waiting on dialysis for a deceased donor transplant.
Authors: Morton J Kern; Amir Lerman; Jan-Willen Bech; Bernard De Bruyne; Eric Eeckhout; William F Fearon; Stuart T Higano; Michael J Lim; Martijn Meuwissen; Jan J Piek; Nico H J Pijls; Maria Siebes; Jos A E Spaan Journal: Circulation Date: 2006-08-28 Impact factor: 29.690
Authors: Rajan Sharma; Eric Chemla; Maite Tome; Rajnikant L Mehta; Helen Gregson; Stephen J D Brecker; Rene Chang; Denis Pellerin Journal: Heart Date: 2006-09-15 Impact factor: 5.994
Authors: José Jayme G De Lima; Luís Henrique W Gowdak; Flávio Jota de Paula; Rodolfo L Arantes; André Luís Veiga de Oliveira; Jose Antonio F Ramires; Luiz Antonio M César; Eduardo M Krieger Journal: Transplantation Date: 2010-04-15 Impact factor: 4.939
Authors: Krista L Lentine; Mark A Schnitzler; Daniel C Brennan; Jon J Snyder; Paul J Hauptman; Kevin C Abbott; David Axelrod; Paolo R Salvalaggio; Bertram Kasiske Journal: Clin J Am Soc Nephrol Date: 2008-04-16 Impact factor: 8.237
Authors: R K Patel; P B Mark; N Johnston; R McGeoch; M Lindsay; D B Kingsmore; H J Dargie; A G Jardine Journal: Am J Transplant Date: 2008-05-28 Impact factor: 8.086
Authors: Tara I Chang; David Shilane; Dhruv S Kazi; Maria E Montez-Rath; Mark A Hlatky; Wolfgang C Winkelmayer Journal: J Am Soc Nephrol Date: 2012-12 Impact factor: 10.121
Authors: Tara I Chang; Maria E Montez-Rath; Thomas T Tsai; Mark A Hlatky; Wolfgang C Winkelmayer Journal: J Am Coll Cardiol Date: 2016-03-29 Impact factor: 24.094
Authors: Ailish Nimmo; Nicholas Latimer; Gabriel C Oniscu; Rommel Ravanan; Dominic M Taylor; James Fotheringham Journal: Transpl Int Date: 2022-06-27 Impact factor: 3.842
Authors: Charles A Herzog; Mengistu A Simegn; Yifan Xu; Salvatore P Costa; Roy O Mathew; Mohammad C El-Hajjar; Sanjeev Gulati; Rafael A Maldonado; Eric Daugas; Magdelena Madero; Jerome L Fleg; Rebecca Anthopolos; Gregg W Stone; Mandeep S Sidhu; David J Maron; Judith S Hochman; Sripal Bangalore Journal: J Am Coll Cardiol Date: 2021-05-11 Impact factor: 27.203
Authors: Andrzej Jaroszyński; Anna Jaroszyńska; Janusz Siebert; Wojciech Dąbrowski; Jarosław Niedziałek; Anna Bednarek-Skublewska; Tomasz Zapolski; Andrzej Wysokiński; Wojciech Załuska; Andrzej Książek; Todd T Schlegel Journal: Clin Exp Nephrol Date: 2015-02-28 Impact factor: 2.801
Authors: Tara I Chang; Maria E Montez-Rath; Jenny I Shen; Matthew D Solomon; Glenn M Chertow; Wolfgang C Winkelmayer Journal: J Am Heart Assoc Date: 2014-10-21 Impact factor: 5.501